Nicholas Miller v. Eagle Pharmaceuticals, Inc., et al., 2:23-cv-23011-MAH
Welcome to the Settlement Website for the Eagle Pharmaceuticals Securities Litigation
If you purchased the publicly traded common stock of Eagle Pharmaceuticals, Inc. between August 9, 2022 and October 1, 2024, both dates inclusive (the "Settlement Class Period"), you may be entitled to receive payment from this class action settlement.
Please read the Notice or review the Frequently Asked Questions page of this website for more information on your rights and options.
These rights and options—and the deadlines to exercise them—are explained further in the Notice and on the Frequently Asked Questions (FAQs) page of this website.
The Court must decide whether to approve the Settlement and the requested attorneys’ Fee Award and Costs. No Settlement Benefits will be provided unless the Court approves the Settlement.